Back

Suboptimal lipoprotein (a) control and residual plaque instability despite proprotein convertase subtilisin/kexin type 9 inhibitor use in heterozygous familial hypercholesterolaemia: insights from serial near-infrared spectroscopy imaging

European Heart Journal

5 April 2021
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE OTHER PREVENTIVE CARDIOLOGY Risk Factors and Prevention BASIC SCIENCE Pharmacology and Pharmacotherapy

Contributors

Kazumasa Imamoto
Kazumasa Imamoto

Author

Yu Kataoka
Yu Kataoka

Author

National Cerebral & Cardiovascular Center Suita , Japan

Hayato Hosoda
Hayato Hosoda

Author

Teruo Noguchi
Teruo Noguchi

Author

You may be interested in
thumbnail
Congress Presentation
Characterization of lipidic coronary atheroma under control of low-density lipoprotein <1.8 mmol/l and lipoprotein (a) <50 mg/dl in patients with coronary artery disease
26 August 2023
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab
1 September 2025
thumbnail
Congress Presentation
Pleiotropic effects of inclisiran on arterial structural and functional parameters
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources